Dow Down 0.92% Nasdaq Down 0.83%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
8.26 Up 0.09(1.10%) Oct 22, 4:00PM EDT
|After Hours : 8.26 0.00 (0.00%) Oct 22, 4:44PM EDT
Prev Close:8.17
Open:8.19
Bid:8.24 x 200
Ask:8.28 x 100
1y Target Est:7.67
Beta:0.65
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:8.06 - 8.30
52wk Range:7.22 - 10.26
Volume:3,202,325
Avg Vol (3m):3,167,520
Market Cap:1.33B
P/E (ttm):4.99
EPS (ttm):1.65
Div & Yield:0.60 (7.50%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 1.10%1.33B
AMGNDown 0.31%109.11B
SGENDown 1.36%4.30B
XOMADown 0.94%452.94M

Key Statistics

Forward P/E (1 yr):3.41
P/S (ttm):2.99
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback